Study analysis · Nutrients · 2024
This milk sugar helped people lose 1.6kg MORE fat—while keeping 750g MORE muscle—during dieting.
Taking a special sugar from breast milk while dieting and walking helped people lose more fat and keep more muscle than those who didn't take it.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study is like a fair test where two groups of people tried to lose weight — one group got a special powder and the other got a fake one. The group with the powder lost more fat and kept more muscle, so we think the powder might help. But we can't say for sure it's the only reason, because not many people were in the study.
What’s the bottom line?
This study tested if adding a special sugar found in breast milk (2'-FL) to a diet and walking plan helps people lose more fat and keep more muscle.
How strong is this study?
This study was done really well — nobody knew who got the real powder or the fake one, and people were randomly assigned. That makes the results trustworthy. But because only 41 people joined, we can't be super sure it will work for everyone — it's like testing a new snack on your class, not the whole school.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
80 / 100
- Randomization+20/20
- Blinding+15/15
- Control group+15/15
- Sample size (n=41)+3.7/20
- Follow-up+10/10
100 / 100
100 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 581 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
This design can establish causation. This study is a randomized controlled trial with blinding and a control group, which allows for causal inference. However, the small sample size (n=41) and multiple secondary outcomes increase the risk of chance findings, so causal claims should be limited to primary outcomes with strong effect sizes and confidence intervals that exclude no effect.
Major COI
Major conflicts that significantly reduce study credibility
The study was funded by a company (Advanced Protein Technologies Corp.) that manufactures the supplement (Momstamin 2′-FL) being tested, and the company provided the experimental supplement, raising significant risk of bias in study design and interpretation.
Funders
Conflict Details
Advanced Protein Technologies Corp.: Provided the experimental supplement (Momstamin 2′-FL) used in the study; manufacturer of the product under investigation.
Advanced Protein Technologies Corp.: Supplement manufactured and supplied by this company; no explicit author employment stated, but close industry tie.
No conflict of interest statement was disclosed in the text. The supplement was provided by the manufacturer, and the dosage was based on extrapolations from animal studies likely conducted by or with industry involvement. The study lacked independent oversight in formulation or analysis, increasing risk of bias. No mention of third-party data analysis or blinded analysis protocols beyond the double-blind design.
Key takeaways
- 01
People who took 3 grams of 2'-FL daily lost 1.6 kg more fat and kept 750g more muscle than those on placebo, while also feeling stronger and more energetic.
- 02
Yes — losing more fat while keeping muscle helps people stay stronger, burn more calories at rest, and avoid rebound weight gain.
Surprising findings
- 2'-FL improved fat oxidation and muscle preservation without changing resting energy expenditure (REE) or total weight loss.Most fat-loss supplements claim to boost metabolism or REE. This one didn’t—yet people lost more fat and kept more muscle, suggesting it works through gut signaling, not calorie-burning.
- Fecal zonulin dropped dramatically despite higher baseline levels in the 2'-FL group.Usually, you’d expect the group with higher initial leakiness to improve less. But 2'-FL reversed it completely—suggesting it’s not just a prebiotic, but a gut barrier repair agent.
- No microbiome analysis was done, yet SCFA levels changed significantly.The study claims 2'-FL works via gut bacteria—but didn’t measure bacteria. Yet acetate, butyrate, and fucose levels shifted, implying microbial activity occurred without direct proof.
Practical takeaways
If you're on a calorie-restricted diet and walking 10k steps/day, consider adding 3g of 2'-FL daily to potentially lose more fat and preserve muscle.
Bone mineral content decreased in the 2'-FL group—don’t use this long-term without monitoring bone health, especially if you’re at risk for osteoporosis.
medium confidenceUse 2'-FL as a gut-support tool during dieting—if you feel bloated or fatigued, it may help repair your intestinal barrier.
This study used a branded supplement (Momstamin 2'-FL); generic versions may not be equivalent. Also, no data on long-term use.
medium confidenceTrack your energy and physical function—not just weight—when trying 2'-FL. The biggest benefit may be feeling stronger, not just looking leaner.
The study only tested 3g/day in overweight adults. Effects may differ in athletes, elderly, or those with metabolic disease.
low confidenceWhy this study matters
Fat Loss Without Muscle Loss
Participants taking 3g/day of 2'-FL lost 1,642g more fat mass than the placebo group (−1,642g vs. −512g, p=0.043), while preserving 750g more fat-free mass (−229g vs. −983g). This happened despite identical weight loss and calorie deficits.
Most diets make you lose muscle along with fat, slowing metabolism and increasing rebound weight gain. This suggests 2'-FL could help people lose fat the 'right way'—keeping strength and burning more calories at rest.
Gut Barrier Repair in 12 Weeks
Fecal zonulin—a marker of 'leaky gut'—dropped significantly in the 2'-FL group (p<0.001), even though their baseline levels were higher. This suggests 2'-FL strengthened the intestinal barrier during calorie restriction.
Leaky gut is linked to inflammation, weight gain, and fatigue. If a simple supplement can fix this during dieting, it could explain why people feel more energetic and less bloated.
Blood Thinner? Not What You Think
Platelet aggregation increased in the placebo group by 2.30 ohms at 6 weeks (p=0.008), but stayed stable in the 2'-FL group. This suggests 2'-FL may have an anti-clotting effect without being a drug.
People think blood thinners are only for heart patients—but this shows a food-derived compound may naturally reduce clot risk during weight loss, a time when inflammation and clotting risk rise.
You Feel Stronger—Even If You Didn't Lift Weights
The 2'-FL group reported significantly better physical function on the SF-36 survey: climbing stairs, walking a mile, bending, and daily energy levels improved more than in the placebo group.
People don't just want to lose weight—they want to feel capable. This study shows 2'-FL didn't just change body composition—it changed how people experienced their own bodies.
The Bone Mineral Mystery
Despite all the benefits, the 2'-FL group lost 22.9g more bone mineral content than placebo (p=0.049)—a small but significant drop that the researchers couldn't explain.
This is the study’s biggest red flag: a supplement that helps fat loss and gut health might hurt bones. It flips the narrative from 'miracle supplement' to 'cautious discovery.'
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
This study tested if adding a special sugar found in breast milk (2'-FL) to a diet and walking plan helps people lose more fat and keep more muscle.
Research results
People who took 3 grams of 2'-FL daily lost 1.6 kg more fat and kept 750g more muscle than those on placebo, while also feeling stronger and more energetic.
What this means - more context
Yes — losing more fat while keeping muscle helps people stay stronger, burn more calories at rest, and avoid rebound weight gain.
This study investigates whether 3 g/day of 2'-fucosyllactose (2'-FL) supplementation enhances body composition and health markers during a 12-week calorie-restricted diet and walking program in overweight sedentary adults.
In a randomized, double-blind, placebo-controlled trial with 41 participants, 2'-FL supplementation significantly improved body fat loss, preserved fat-free mass, enhanced resting fat oxidation, reduced platelet aggregation, improved intestinal barrier integrity (lower zonulin), and increased self-reported physical function and quality of life compared to placebo, despite similar weight loss between groups.
Methods Used
41 overweight sedentary adults (BMI 25–40) were randomized to 3 g/day of 2'-FL or placebo while following a 300 kcal/day energy deficit and 10,000 steps/day walking program for 12 weeks. Outcomes were measured via DEXA, metabolic carts, blood tests, fecal zonulin, NMR metabolomics, and SF-36 surveys using repeated-measures GLM with 95% CIs.
Main Finding
2'-FL supplementation (3 g/day) during weight loss significantly increased fat mass loss (−1642 g vs. −512 g in placebo, p=0.043), reduced fat-free mass loss, improved resting fat oxidation, lowered fecal zonulin (p<0.001), reduced platelet aggregation (p=0.008 at 6 weeks), and improved self-reported physical function and quality of life.
Confidence Level
Moderate to high — study is a well-conducted RCT with blinding, randomization, pre-registration, and use of 95% CIs and effect sizes; however, small sample size (n=41) and lack of microbiome analysis limit generalizability.
Study Flags
Red Flags
- •Small sample size (n=41)
- •Unexplained reduction in bone mineral content with 2'-FL
- •No direct gut microbiome analysis performed
Surprising Findings
2'-FL improved fat oxidation and muscle preservation without changing resting energy expenditure (REE) or total weight loss.
Most fat-loss supplements claim to boost metabolism or REE. This one didn’t—yet people lost more fat and kept more muscle, suggesting it works through gut signaling, not calorie-burning.
Practical Takeaways
If you're on a calorie-restricted diet and walking 10k steps/day, consider adding 3g of 2'-FL daily to potentially lose more fat and preserve muscle.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 581 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Human RCT
Subject
High probability
on the GRADE evidence scale
This study is like a fair test where two groups of people tried to lose weight — one group got a special powder and the other got a fake one. The group with the powder lost more fat and kept more muscle, so we think the powder might help. But we can't say for sure it's the only reason, because not many people were in the study.
Major conflicts — industry funding with significant control over the research. Reporting score and overall score cap have been reduced.
Strengths
- Randomized, double-blind, placebo-controlled design
- Clear inclusion/exclusion criteria and pre-registration (NCT06547801)
- Use of validated instruments (DXA, VO2 max, SF-36, IPAQ)
Weaknesses
- Small sample size (n=41) increases risk of Type II error and overestimation of effect sizes
- Multiple secondary outcomes increase risk of false positives (chance findings)
- No adjustment for multiple comparisons in secondary outcomes
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
This study tested if adding a special sugar found in breast milk (2'-FL) to a diet and walking plan helps people lose more fat and keep more muscle.
Research results
People who took 3 grams of 2'-FL daily lost 1.6 kg more fat and kept 750g more muscle than those on placebo, while also feeling stronger and more energetic.
What this means - more context
Yes — losing more fat while keeping muscle helps people stay stronger, burn more calories at rest, and avoid rebound weight gain.
This study investigates whether 3 g/day of 2'-fucosyllactose (2'-FL) supplementation enhances body composition and health markers during a 12-week calorie-restricted diet and walking program in overweight sedentary adults.
In a randomized, double-blind, placebo-controlled trial with 41 participants, 2'-FL supplementation significantly improved body fat loss, preserved fat-free mass, enhanced resting fat oxidation, reduced platelet aggregation, improved intestinal barrier integrity (lower zonulin), and increased self-reported physical function and quality of life compared to placebo, despite similar weight loss between groups.
Methods Used
41 overweight sedentary adults (BMI 25–40) were randomized to 3 g/day of 2'-FL or placebo while following a 300 kcal/day energy deficit and 10,000 steps/day walking program for 12 weeks. Outcomes were measured via DEXA, metabolic carts, blood tests, fecal zonulin, NMR metabolomics, and SF-36 surveys using repeated-measures GLM with 95% CIs.
Main Finding
2'-FL supplementation (3 g/day) during weight loss significantly increased fat mass loss (−1642 g vs. −512 g in placebo, p=0.043), reduced fat-free mass loss, improved resting fat oxidation, lowered fecal zonulin (p<0.001), reduced platelet aggregation (p=0.008 at 6 weeks), and improved self-reported physical function and quality of life.
Confidence Level
Moderate to high — study is a well-conducted RCT with blinding, randomization, pre-registration, and use of 95% CIs and effect sizes; however, small sample size (n=41) and lack of microbiome analysis limit generalizability.
Study Flags
Red Flags
- •Small sample size (n=41)
- •Unexplained reduction in bone mineral content with 2'-FL
- •No direct gut microbiome analysis performed
Surprising Findings
2'-FL improved fat oxidation and muscle preservation without changing resting energy expenditure (REE) or total weight loss.
Most fat-loss supplements claim to boost metabolism or REE. This one didn’t—yet people lost more fat and kept more muscle, suggesting it works through gut signaling, not calorie-burning.
Practical Takeaways
If you're on a calorie-restricted diet and walking 10k steps/day, consider adding 3g of 2'-FL daily to potentially lose more fat and preserve muscle.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 581 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Human RCT
Subject
High probability
on the GRADE evidence scale
This study is like a fair test where two groups of people tried to lose weight — one group got a special powder and the other got a fake one. The group with the powder lost more fat and kept more muscle, so we think the powder might help. But we can't say for sure it's the only reason, because not many people were in the study.
Major conflicts — industry funding with significant control over the research. Reporting score and overall score cap have been reduced.
Strengths
- Randomized, double-blind, placebo-controlled design
- Clear inclusion/exclusion criteria and pre-registration (NCT06547801)
- Use of validated instruments (DXA, VO2 max, SF-36, IPAQ)
Weaknesses
- Small sample size (n=41) increases risk of Type II error and overestimation of effect sizes
- Multiple secondary outcomes increase risk of false positives (chance findings)
- No adjustment for multiple comparisons in secondary outcomes
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
This study was done really well — nobody knew who got the real powder or the fake one, and people were randomly assigned. That makes the results trustworthy. But because only 41 people joined, we can't be super sure it will work for everyone — it's like testing a new snack on your class, not the whole school.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
80 / 100
- Randomization+20/20
- Blinding+15/15
- Control group+15/15
- Sample size (n=41)+3.7/20
- Follow-up+10/10
100 / 100
100 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 581 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
This design can establish causation. This study is a randomized controlled trial with blinding and a control group, which allows for causal inference. However, the small sample size (n=41) and multiple secondary outcomes increase the risk of chance findings, so causal claims should be limited to primary outcomes with strong effect sizes and confidence intervals that exclude no effect.
Major COI
Major conflicts that significantly reduce study credibility
The study was funded by a company (Advanced Protein Technologies Corp.) that manufactures the supplement (Momstamin 2′-FL) being tested, and the company provided the experimental supplement, raising significant risk of bias in study design and interpretation.
Funders
Conflict Details
Advanced Protein Technologies Corp.: Provided the experimental supplement (Momstamin 2′-FL) used in the study; manufacturer of the product under investigation.
Advanced Protein Technologies Corp.: Supplement manufactured and supplied by this company; no explicit author employment stated, but close industry tie.
No conflict of interest statement was disclosed in the text. The supplement was provided by the manufacturer, and the dosage was based on extrapolations from animal studies likely conducted by or with industry involvement. The study lacked independent oversight in formulation or analysis, increasing risk of bias. No mention of third-party data analysis or blinded analysis protocols beyond the double-blind design.